CVS to Limit Opioid Prescriptions to a Seven-Day Supply to Address Opioid Crisis – APhA submits compounding comments to FDA. – (866) 348-2889
In an effort to address the nation’s opioid abuse epidemic, CVS will become the first retail chain pharmacy to limit opioid prescriptions to a seven-day supply for certain conditions. Under its new initiative, CVS will be:
- Limiting the supply of opioids dispensed to seven days for certain acute prescriptions for patients who are new to therapy;
- Limiting the daily dosage of opioids dispensed based on the strength of the opioid; and
- Requiring the use of immediate-release formulations of opioids before extended-release opioids are dispensed.
Additionally, CVS Pharmacy locations will strengthen counseling and educate patients about the Centers for Disease Control and PreventionGuideline for Prescribing Opioids for Chronic Pain, which advises using the lowest effective dose for the shortest duration possible. For patients filling an opioid prescription, pharmacists will counsel patients about the risk of dependence and addiction tied to duration of opioid use, the importance of keeping medications secure in the home, and methods of proper disposal of unused medication.